CULLINAN THERAPEUTICS INC (CGEM) Stock Income Statement
NASDAQ:CGEM - Nasdaq - US2300311063 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 18.94M | 0.00 | |||
| Minority Interest Expense | 192.00K | 1.94M | 2.02M | 1.92M | 7.66M | |||
| Operating Expenses | 196.92M | 190.65M | 130.14M | 86.90M | 60.34M | |||
| Research and Development | 142.90M | 148.16M | 91.95M | 57.75M | 43.21M | |||
| Selling, General, and Administrative Expenses | 54.02M | 42.49M | 38.19M | 29.15M | 17.12M | |||
| Operating Income | -196.92M | -190.65M | -130.14M | -67.95M | -60.34M | |||
| Interest Income/Expense | 29.66M | 21.63M | 6.61M | 480.00K | 890.00K | |||
| Other Income/Expense | -199.00K | 239.00K | 60.00K | -10.00K | -10.00K | |||
| Non Recurring Items | 0.00 | -440.00K | 274.79M | N/A | N/A | |||
| Income Before Taxes | -167.46M | -169.22M | 151.32M | -67.49M | -59.46M | |||
| Income Tax | 117.00K | -14.12M | 42.12M | N/A | N/A | |||
| Net Income | -167.38M | -153.16M | 111.21M | -65.57M | -51.80M | |||
| EBITDA | -196.61M | -190.34M | -130.05M | -67.90M | -60.28M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.11 | -3.69 | 2.38 | -1.52 | -1.25 | |||
| Non GAAP EPS | -3.03 | -3.69 | 2.37 | -1.50 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -346.20% | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | -358.76% | N/A | |||
All data in USD